Although the role of platelets in hemostasis and thrombotic disorders as well as their contribution to inflammation are known, recent studies support the notion that much remains to be learned about platelet bioenergetics. Recent data suggest that platelets possess extra-mitochondrial oxidative phosphorylation (OXPHOS), which could represent one of sources of the chemical energy necessary for the prompt platelets activation. However, the extra-mitochondrial OXPHOS can play both beneficial and pathological roles, since the OXPHOS is the principal responsible of oxidative stress generation. For this reason, several authors evaluated the effects of polyphenols and other antioxidants on the modulation of the platelets oxidative stress production. In conclusion, we believe that a better understanding of platelet oxidative metabolism would allow a deeper knowledge of their physiology and the designing novel treatments targeting the role of platelets in many human diseases.
with branching ends [2, 3] . The fourth developmental stage is thrombocytopoiesis: platelet release, promoted by shear forces [2, 3] . Mature platelet lifetime in the blood is about 7 days.
Platelets are "first responders" promptly sensing endothelial damage initiating clotting [1] , but they can also react to circulating pathogens [4] . Platelet remarkable reactivity justifies their involvement in coagulative dysfunctions and thrombotic disorders [5] . Recent evidence supports the notion that platelets can also play a pivotal role in cancer progression, promoting tumorigenesis through factor secretion and metastasis to form immune-evasive aggregates with tumour cells [6] . Platelet dysfunction appears involved in complications of type II diabetes mellitus (DM): hyperglycemia would increase platelet mitochondrial ATP content [7] , but it was also shown that platelet oxidative phosphorylation (OXPHOS) was impaired in type II DM [8] . Mitochondrial complex I activity was found to be decreased in aged platelets [9] .
PLATELET BIOENERGETICS
The rapid response rate of platelet activation involves dramatic shape changes, i.e., loss of discoid form, dynamic filopodia formation [6] . This phenomenon is significantly increased in stenosed arteries in vivo, consistent with the role of platelets in vascular disease [10] . Platelets, being anucleate, possess a stable metabolic program over their lifetime to meet their physiological energetic demand and expenditure during their activation. The integrated bioenergetic machinery involves both glycolysis and OXPHOS [11, 12] . While at a basal state both aerobic metabolism and glycolysis play a role in energy production in platelets production, OXPHOS is required for agonist-stimulated platelet activation [12] [13] [14] . One study reported that platelets rely on OXPHOS also in basal conditions [15] . Authors studied the basal oligomycin-sensitive mitochondrial oxygen consumption rate (OCR) and glycolytic flux (ECAR), showing that human platelets from healthy donors have a low ECAR value in face of the highest basal OCR one with respect to nucleate blood cells, meaning that platelets are the most metabolically active figurative elements of the circulating blood. Accordingly, the mitochondrial platelet functioning is remarkable and it has been largely studied [13] [14] [15] , since platelets are considered a valuable biomarker of mitochondrial pathologies [5, 8, 16] .
NEW PERSPECTIVES ON OXIDATIVE METABOLISM IN PLATELETS
Although platelets metabolism is sustained by the OXPHOS, it seems that there is a mismatch among the platelet elevated aerobic metabolism and their mitochondria number [14, 17] . We have recently shown, by TEM microscopy, that two is the average mitochondria number of platelets and several of them being devoid of mitochondria [18] . Notably, as far as the maturation process is involved, the number of platelets released per MK ranges from 2000-11,000 platelet per MK [2] . This implies that, even though the MK cytoplasm organizes itself forming dense bodies, secretory vesicles so that vital organelles are found within the nascent platelets, the mature MK should contain some 8000 mitochondria on the average, to guarantee that at least one mitochondrion resides in each platelet, which does not seem to be the case. Therefore, mitochondria may not be sufficient to produce the large amount of energy required for platelet rapid activation involving cytoskeletal rearrangements, and sudden shape changes [19] , suggesting that other structures may be involved in the aerobic energy generation.
We have recently shown that platelets display a consistent oxygen consumption and ATP production in the presence of NADH, a respiring substrate not suitable for mitochondria in vitro. This NADH-stimulated oxygen consumption appeared sensitive to thrombin or collagen and insensitive to atractyloside, an inhibitor of Adenine nucleotide translocase [18] , suggesting that other structures are involved in platelets respiration besides mitochondria. Moreover, in platelets, the ratio of the expression of F 1 F o -ATP synthase and the translocase of the inner membrane (TIM; a mitochondrial inner membrane protein not involved in the OXPHOS) was higher than in mitochondria [18] . Since, in mitochondria, the proportion of these two proteins is conserved, this was considered a clue to the fact that ATP synthase could be also expressed in the internal platelet membranes. In other words, our study suggested the existence of an extramitochondrial energy production in platelets [18] [ Figure 1 ]. This hypothesis is confirmed by the confocal microscopy analysis, which shows a low signal of TIM in the face of a strong colocalization between COXII or β subunit of ATP synthase with calnexin, a marker of the endoplasmic reticulum (ER).
As far as the extramitochondrial respiration is concerned, the main difference respect to mitochondrial one is the absence of a double membrane system, supposedly necessary to accumulate the proton gradient, Figure 1 . Scheme of metabolic flux in platelets. The scheme describes the energy production in platelets, carried out by the extramitochondrial structures. Glucose is converted in pyruvate by the glycolysis pathway with the production of 2 molecules of ATP and NADH. Since, in our model, the proton gradient is formed at the center of the membrane, the NADH produced by glycolysis could transfer its electrons and protons directly to complex I, triggering the extramitochondrial respiration and the relative ATP synthesis on both sides of the membrane. Moreover, also the hypothetical extramitochondrial Krebs cycle could represent a source of reduced coenzymes for the ectopic respiration. CI: complex I; C II: complex II; C III: complex III; C IV: complex IV; e-: electron; H+: proton; a: a subunit of Fo moiety; OAA: oxalacetic acid; aKG: a-ketoglutarate according to Mitchell's theory. However, in two of our previous papers, a proton delivery at the center of a membrane expressing the electron transfer chains has been proposed [20, 21] . In particular, this model supposed that the proton movement inside the membranes occurs as a moving charge, according to the proton-hopping Grotthuss mechanism, with the establishment of "protonic currents" inside the membrane. These would allow the ATP synthesis on both sides of the membrane, as schematized in Figure 1 . Therefore, based on this model, we can speculate that the NADH produced by glycolysis, could be used directly by the respiratory Complex I present on the platelet membranous structures, triggering the extramitochondrial OXPHOS. Moreover, considering that the expression of the cytosolic form of Krebs enzymes is well described, we can also speculate that an extramitochondrial Krebs cycle in platelets could represent another source of reduced coenzymes for the ectopic OXPHOS. On the other hand, we have demonstrated the functional expression of an extramitochondrial Krebs cycle both in disks and in myelin vesicles [22, 23] .
We have also reported the functional ectopic expression of the OXPHOS machinery in the rod outer segments and the myelin sheath [22, [24] [25] [26] . However, a number of reports showed the expression of the five redox complexes in other systems in many membranous structures devoid of mitochondria (reviewed in Ref. [27] ), some of which were found biochemically active [28] [29] [30] . On the other hand, it is reasonable believe that a mechanism as the extramitochondrial aerobic metabolism may not be exclusive of the nervous system, but exploited when a considerable amount of ATP is needed, such as in cancer cells [28, 31] . Moreover, the exportability of mitochondrial proteins is suggested by the strictly interaction and membrane trafficking between mitochondria and the other cellular membranous structure, i.e., ER [32] .
POTENTIAL SOURCES OF OXIDATIVE STRESS IN PLATELETS
Oxidative stress is the consequence of an unbalance among the intracellular overproduction of reactive oxygen species (ROS) and the intracellular antioxidant response [33] . Oxidative stress is considered a common mechanism underlying many human diseases [34] . An important source of ROS in platelets is NADPH oxidase [35] , however, the main source of ROS is the electron transport chain (ETC) [36] . The existence of an extra-mitochondrial ETC in platelets is suggestive of an unsuspected source of ROS production outside the mitochondrion [37, 38] . Oxidative stress plays both beneficial and pathological roles in platelets, acting both in the regulation of platelet responses and in the pathological process of atherothrombosis [39, 40] and platelet apoptosis [5] . This dual [37, 38] role of ROS in platelets would justify the ectopic expression of the ETC itself. In fact, an extra-mitochondrial ROS production would avoid the damage to mitochondrial membranes consequent to ROS production, potentially dangerous, as these contain mitochondrial damage-associated molecular patterns, which can activate inflammation.
ANTIOXIDANTS
Multiple lines of evidence suggest that the addition of exogenous antioxidants to the diet plays a role in the prevention of oxidative stress [41] . In particular, polyphenols, Vitamins E, A and C or n-3 PUFA appear to bear a potential interest. In the last years, several antioxidant molecules have been tested as potential inhibitors of platelets aggregation, but only some of these showed a strong positive effect [ Table 1 ].
Notably, mixes of antioxidant molecules extracted from the food seem to be more active in the inhibition of platelets aggregation with respect the single antioxidant molecule. However, the proper choice of the antioxidant should pay attention to its ability to cross multiple membranes and to avoid an excess of reduced molecules, since an excess of reducing equivalents causes reductive stress, which displays a strong negative effect on the cellular homeostasis [42] .
CONCLUSION
In conclusion, taking into consideration the possibility that platelets may be privileged sites of extramitochondrial aerobic metabolism could allow us to better understand their physio-pathology. The reliance of platelet on aerobic metabolism in face of a limited number of small mitochondria, the developed membrane system inside the platelets and the above considerations raise the hypothesis that the high oxygen consumption and the consequent free radical production can be ascribed to the ectopic OXPHOS. A deeper knowledge of the platelet bioenergetics would allow designing new treatments targeting the pivotal role of platelets in many human diseases, developing in vitro strategies to manufacture platelet products for both adult and paediatric patients, and choosing the best antioxidant therapy. We have recently shown that polyphenols have the ability to hamper the production of free radicals modulating the activity of the extra-mitochondrial respiratory chains binding the ectopic ATP synthase [38] . Future studies on the role of polyphenols supplementation on platelet aggregation in humans may benefit from this novel and challenging perspective. a: fibrinogen-induced (0.1%); b: ADP-induced (5 µM); c: collagen-induced (2 µg/mL); d: ADP-induced (1 µM); e: collagen-induced (25 µg/mL); f: thrombin-induced (0.25 U/mL). NDGA: nordihydroguaiaretic acid; EGCG: epigallocatechin gallate; DHPE: 2-(3,4-dihydroxyphenyl)-ethanol DECLARATIONS
